Hyderabad Telangana, India

Adla Malla Reddy

This inventor holds 7 USPTO granted patents and 5 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2012-2015.


% Patents Active = 57.1

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Andhra Pradesh, IN (2012 - 2013)
  • Hyderabad, IN (2014 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Adla Malla Reddy: Innovator in Anti-Cancer Research

Introduction

Adla Malla Reddy is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of anti-cancer research, holding a total of 7 patents. His work focuses on developing compounds that have the potential to combat human cancer cell lines.

Latest Patents

Among his latest patents is a groundbreaking invention related to Amidobenzothiazoles. This invention provides a compound of general formulae A, which is useful as a potential anti-cancer agent against human cancer cell lines. Additionally, he has developed 2-anilinonicotinyl based chalcones, which are also aimed at serving as potential antitumor agents against human cancer cell lines. Both patents include processes for the preparation of these compounds, showcasing his innovative approach to cancer treatment.

Career Highlights

Adla Malla Reddy is affiliated with the Council of Scientific and Industrial Research, where he has been instrumental in advancing research in medicinal chemistry. His dedication to innovation in the pharmaceutical field has positioned him as a key figure in the fight against cancer.

Collaborations

He has collaborated with notable colleagues, including Ahmed Kamal and Kamal Ahmed, to further enhance the impact of his research. Their combined efforts have contributed to the development of effective anti-cancer agents.

Conclusion

Adla Malla Reddy's contributions to anti-cancer research through his patents and collaborations highlight his commitment to innovation in the medical field. His work continues to inspire advancements in cancer treatment and research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…